Intrinsic Value of S&P & Nasdaq Contact Us

Xylem Inc. XYL NYSE

NYSE • Industrials • Industrial - Machinery • US • USD

SharesGrow Score
69/100
3/7 Pass
SharesGrow Intrinsic Value
$170.88
+31.8%
Analyst Price Target
$162.67
+25.5%

Xylem Inc. (XYL) generated $1.24B in operating cash flow for fiscal year 2025. After capital expenditures of $331M, free cash flow was $910M.

Free cash flow margin was 10.1% of revenue. Cash conversion ratio was 1.31x, indicating earnings are backed by cash.

The company returned $391M in dividends and $15M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
  • MOAT (62/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (55/100) — Cash conversion ratio was 1.31x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 69/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
69/100
SG Score
View full scorecard →
VALUE
32/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
62/100
Proven by this page
GROWTH
90/100
→ Income
~
INCOME
55/100
→ Income
Xylem Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $1.24B$1.24B$1.26B$837M$596M
Capital Expenditure $-331M$-331M$-321M$-271M$-208M
Free Cash Flow $910M$910M$942M$566M$388M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message